These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30638282)

  • 1. Synthesis, CYP 450 evaluation, and docking simulation of novel 4-aminopyridine and coumarin derivatives.
    Ghalehshahi HG; Balalaie S; Sohbati HR; Azizian H; Alavijeh MS
    Arch Pharm (Weinheim); 2019 Mar; 352(3):e1800247. PubMed ID: 30638282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of new Coumarin-based profluorescent substrates for human cytochrome P450 enzymes.
    Juvonen RO; Ahinko M; Huuskonen J; Raunio H; Pentikäinen OT
    Xenobiotica; 2019 Sep; 49(9):1015-1024. PubMed ID: 30272491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
    Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
    Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, syntheses, structure-activity relationships and docking studies of coumarin derivatives as novel selective ligands for the CB2 receptor.
    Han S; Zhang FF; Qian HY; Chen LL; Pu JB; Xie X; Chen JZ
    Eur J Med Chem; 2015 Mar; 93():16-32. PubMed ID: 25644673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
    An R; Hou Z; Li JT; Yu HN; Mou YH; Guo C
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30200625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, biological evaluation, and molecular modeling of coumarin-piperazine derivatives as acetylcholinesterase inhibitors.
    Modh RP; Kumar SP; Jasrai YT; Chikhalia KH
    Arch Pharm (Weinheim); 2013 Nov; 346(11):793-804. PubMed ID: 24591157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking studies of fused coumarin derivatives as inhibitors of GlcN-6.
    Govori S; Haziri A; Ademi K; Neziraj N
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2017 Sep; 52(11):1041-1045. PubMed ID: 28737449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
    Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A
    Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-soluble PDE4 inhibitors for the treatment of dry eye.
    Govek SP; Oshiro G; Anzola JV; Beauregard C; Chen J; Coyle AR; Gamache DA; Hellberg MR; Hsien JN; Lerch JM; Liao JC; Malecha JW; Staszewski LM; Thomas DJ; Yanni JM; Noble SA; Shiau AK
    Bioorg Med Chem Lett; 2010 May; 20(9):2928-32. PubMed ID: 20378348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studies.
    Karataş MO; Uslu H; Sarı S; Alagöz MA; Karakurt A; Alıcı B; Bilen C; Yavuz E; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016 Oct; 31(5):760-72. PubMed ID: 26207513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking oestradiol synthesis pathways with potent and selective coumarin derivatives.
    Niinivehmas S; Postila PA; Rauhamäki S; Manivannan E; Kortet S; Ahinko M; Huuskonen P; Nyberg N; Koskimies P; Lätti S; Multamäki E; Juvonen RO; Raunio H; Pasanen M; Huuskonen J; Pentikäinen OT
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):743-754. PubMed ID: 29620427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Phenylcoumarin Derivatives: Design, Synthesis, and Vasodilatory Activity.
    Wang C; Li Y; Zhang T; Wei D; Hou Y; He H
    Chem Biodivers; 2018 Nov; 15(11):e1800255. PubMed ID: 30194801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.
    Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA
    Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives.
    Srivastava P; Vyas VK; Variya B; Patel P; Qureshi G; Ghate M
    Bioorg Chem; 2016 Aug; 67():130-8. PubMed ID: 27376460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical evaluation of ADMET properties for coumarin derivatives as compounds with therapeutic potential.
    Żołek T; Maciejewska D
    Eur J Pharm Sci; 2017 Nov; 109():486-502. PubMed ID: 28867490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design, synthesis, biological evaluation, homology and docking studies of coumarin derivatives as α1 -adrenoceptor antagonists.
    Zhou X; Chen YD; Wang T; Wang XB; Kong LY
    Chem Biodivers; 2011 Jun; 8(6):1052-64. PubMed ID: 21674779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, immunocytochemistry evaluation, and molecular docking investigation of several 4-aminopyridine derivatives as potential neuroprotective agents for treating Parkinson's disease.
    Li S; Wei D; Mao Z; Chen L; Yan X; Li Y; Dong S; Wang D
    Bioorg Chem; 2017 Aug; 73():63-75. PubMed ID: 28618343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
    Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
    Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
    Paul K; Bindal S; Luxami V
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.